Macrolide Resistance in Mycoplasma pneumoniae, Midwestern United States, 2014 to 2021-Reference-Cited by-同舟云学术

Macrolide Resistance in Mycoplasma pneumoniae, Midwestern United States, 2014 to 2021

Published:2022-04-19 Issue:4 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Rothstein Tanner E.¹,Cunningham Scott A.¹,Rieke Rachelle A.¹,Mainella Jill M.¹,Mutchler Melissa M.¹,Patel Robin¹²^ORCID

Affiliation:

1. Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

2. Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA

Abstract

The epidemiology of macrolide resistance inMycoplasma(Mycoplasmoides)pneumoniaein the United States is incompletely described. Using a PCR assay targeting common mutations associated with macrolide resistance inM. pneumoniae(23S rRNA gene, A2063G/A2064G), the frequency of macrolide resistance was estimated to be 10% based on analysis of 114 samples tested from January 2014 to September 2021 at Mayo Clinic Laboratories.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.02432-21

Reference11 articles.

1. Waites KT-R, et al. 2011. Mycoplasma and Ureaplasma, p 970–985. In Versalovic J, Carroll KC, Jorgensen JG, Funke G, Landry ML, Warnock DW (ed), Manual of clinical microbiology, 10th ed. ASM Press, Washington, DC.

2. New insights in the outbreak pattern of Mycoplasma pneumoniae

3. Mycoplasma pneumoniae – A National Public Health Perspective

4. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program

5. Mycoplasma pneumoniae from the Respiratory Tract and Beyond

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The epidemic characteristics of Mycoplasma pneumoniae infection among children in Anhui, China, 2015–2023;Microbiology Spectrum;2024-09-03

2. Expert consensus on the diagnosis and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children;World Journal of Pediatrics;2024-08-14

3. miRNA, lncRNA and circRNA: targeted molecules with therapeutic promises in Mycoplasma pneumoniae infection;Archives of Microbiology;2023-07-21

4. Clinical Value of Metagenomics Next-Generation Sequencing in Antibiotic Resistance of a Patient with Severe Refractory Mycoplasma pneumoniae Pneumonia: A Case Report;Infection and Drug Resistance;2023-07

5. Clinical characteristics of community-acquired pneumonia in children caused by mycoplasma pneumoniae with or without myocardial damage: A single-center retrospective study;World Journal of Clinical Pediatrics;2023-06-09